BMAP-18

Overview

BMAP-18 is a potent truncated form of the antimicrobial peptide BMAP-27, derived from bovine myeloid sources. Recognized for its role in the Cathelicidin family of peptides, BMAP-18 exhibits rapid bactericidal activity, particularly against harmful bacteria such as Staphylococcus aureus, Streptococcus uberis, and Escherichia coli. What makes BMAP-18 stand out is its enhanced cell selectivity compared to its precursor, BMAP-27. This selectivity means that while BMAP-27 can cause cytotoxic effects on human erythrocytes and neutrophils at higher concentrations, BMAP-18 performs effectively with reduced toxicity.

Key Features

• Truncated version of BMAP-27 for improved selectivity
• Effective against a range of pathogenic bacteria
• High bactericidal activity with minimized cytotoxicity
• Part of the Cathelicidin peptide family
• Ideal for research in antimicrobial therapies

Specifications

FAQ

What is BMAP-18 used for?

BMAP-18 is primarily used in research focused on antimicrobial therapies. Its unique properties make it suitable for studying bacterial infections and developing new treatment methods.

How does BMAP-18 differ from BMAP-27?

BMAP-18 is a truncated version of BMAP-27 with better cell selectivity, which means it targets bacteria more effectively while causing less harm to human cells.

Where can I find other peptide products?

For a complete range of peptide options, check out our peptides catalog. We offer various peptides designed for different applications, ensuring you find the right one for your needs.

If you’re looking to buy BMAP-18 or need more information on how it can fit your research needs, visit our store today and explore the potent benefits of this antimicrobial peptide.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled